3784 |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY Q MEMBER 1 |
KCNQ1 |
ATFB1 |
ATFB3 |
JLNS1 |
KCNA8 |
KCNA9 |
KVLQT1 |
Kv1.9 |
Kv7.1 |
LQT |
LQT1 |
RWS |
SQT2 |
WRS |
607542 |
6294 |
ENSG00000053918 |
OTTHUMG00000009900 |
Voltage-gated potassium channel subunit Kv7.1 |
KQT-like 1 |
IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 |
Potassium voltage-gated channel subfamily KQT member 1 |
P51787 |
KCNQ1_HUMAN |
PA223 |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY KQT MEMBER 1 (VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT KV7.1) (IKS PRODUCING SLOW VOLTAGE-GATED POTASSIUM CHANNEL ALPHA SUBUNIT KVLQT1) (KQT-LIKE 1). [SOURCE:UNIPROT/SWISSPROT;ACC:P51787] |
Voltage-gated potassium channel Kv7.1 |
T49526 |
Initial Gene Query | Kv7.1 |
Counted Citations from 1950-2000 | 1149 |
Human Readable Name | ION CHANNEL |
Uniprot Status | Swiss-Prot |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | Ion_trans_dom |
Interpro Name | Ion transport domain |
Interpro Acc | IPR005821 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Domain |
Target Subclass | Potassium_channels |
Target Subclass | Channels |
Transmembrane Helix Count | 6 |
Target Subclass | Voltage_gated_ion_channels |
Target Main Class | Transporters |
Target Class | Transporters |
Target Subclass | TC:1.A.1.15.6 |
Gene Biotype | PROTEIN_CODING |
CELL SURFACE |
ION CHANNEL |
DRUGGABLE GENOME |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
blocker (inhibitory) |
Trial Name | retigabine, ezogabine,Potiga |
Novel drug target | Established target |
Mechanism of Interaction | KCNQ (Kv7) potassium channel blocker |
n/a |
Novel drug target | Established target |
Trial Name | Indaflex |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
blocker (inhibitory) |
Mechanism of Interaction | Voltage-gated potassium channel blocker |
Direct Interaction | yes |
KCNQ1 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
3784 | Entrez Gene Id |
ENSG00000053918 | Ensembl Gene Id |
P51787 | Uniprot Accession |
Human Readable Name | ION CHANNEL |
Uniprot Status | Swiss-Prot |
Uniprot Evidence | 1: Evidence at protein level |
ION CHANNEL, DRUGGABLE GENOME |
3784 | Entrez Gene Id |
KCNQ1_HUMAN | Uniprot Id |
P51787 | Uniprot Accession |
Target Subclass | Potassium_channels |
Target Subclass | Channels |
Transmembrane Helix Count | 6 |
3784 | Entrez Gene ID |
Initial Gene Query | Kv7.1 |
Counted Citations from 1950-2000 | 1149 |
ION CHANNEL |
KCNQ1 | Gene Symbol |
Target Class | Transporters |
Target Subclass | TC:1.A.1.15.6 |
KCNQ1 | Display Id |
ENSG00000053918 | Ensembl Gene Id |
POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY KQT MEMBER 1 (VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT KV7.1) (IKS PRODUCING SLOW VOLTAGE-GATED POTASSIUM CHANNEL ALPHA SUBUNIT KVLQT1) (KQT-LIKE 1). [SOURCE:UNIPROT/SWISSPROT;ACC:P51787] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
PA223 | PharmGKB ID |
ENSG00000053918 | Gene Symbol |
KCNQ1 | Ensembl Id |
DRUGGABLE GENOME |
KCNA9 | GENE_SYMBOL |
KVLQT1 | GENE_SYMBOL |
KCNQ1 | GENE_SYMBOL |
KCNA8 | GO Gene Synonym |
KCNA9 | GO Gene Synonym |
KVLQT1 | GO Gene Synonym |
CELL SURFACE |
KCNQ1 | TTD Gene Abbreviation |
T49526 | TTD Target ID |
Potassium voltage-gated channel subfamily KQT member 1 | Gene Name |
P51787 | UniProt ID |
ION CHANNEL |